Health
AB Science Patent Granted
AB Science’s Masitinib Receives U.S. Patent Acceptance for Sickle Cell Disease Treatment, offering New Hope for Patients Paris, April 14, 2025, 6 p.m. CET By
April 14, 2025
No Comments
© 2025 All rights reserved